These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 34706797)

  • 21. pH and redox dual-sensitive polysaccharide nanoparticles for the efficient delivery of doxorubicin.
    Yang S; Tang Z; Zhang D; Deng M; Chen X
    Biomater Sci; 2017 Sep; 5(10):2169-2178. PubMed ID: 28914292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pullulan-Based Nanoparticle-HSA Complex Formation and Drug Release Influenced by Surface Charge.
    Yuan L; Cao Y; Luo Q; Yang W; Wu X; Yang X; Wu D; Tan S; Qin G; Zhou J; Zeng Y; Chen X; Tao X; Zhang Q
    Nanoscale Res Lett; 2018 Oct; 13(1):317. PubMed ID: 30306404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multifunctional Polyethylene Glycol (PEG)-Poly (Lactic-Co-Glycolic Acid) (PLGA)-Based Nanoparticles Loading Doxorubicin and Tetrahydrocurcumin for Combined Chemoradiotherapy of Glioma.
    Zhang X; Zhao L; Zhai G; Ji J; Liu A
    Med Sci Monit; 2019 Dec; 25():9737-9751. PubMed ID: 31856143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual-targeting nanoparticles with core-crosslinked and pH/redox-bioresponsive properties for enhanced intracellular drug delivery.
    Zhao J; Yan C; Chen Z; Liu J; Song H; Wang W; Liu J; Yang N; Zhao Y; Chen L
    J Colloid Interface Sci; 2019 Mar; 540():66-77. PubMed ID: 30634060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery.
    Thambi T; Deepagan VG; Yoon HY; Han HS; Kim SH; Son S; Jo DG; Ahn CH; Suh YD; Kim K; Kwon IC; Lee DS; Park JH
    Biomaterials; 2014 Feb; 35(5):1735-43. PubMed ID: 24290696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-Assembled Cationic Biodegradable Nanoparticles from pH-Responsive Amino-Acid-Based Poly(Ester Urea Urethane)s and Their Application As a Drug Delivery Vehicle.
    He M; Potuck A; Kohn JC; Fung K; Reinhart-King CA; Chu CC
    Biomacromolecules; 2016 Feb; 17(2):523-37. PubMed ID: 26650653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of Epirubicin-Loaded Biocompatible Polymer PLA-PEG-PLA Nanoparticles: Synthesis, Characterization, Stability, and In Vitro Anticancerous Assessment.
    Massadeh S; Almohammed I; Barhoush E; Omer M; Aldhawi N; Almalik A; Alaamery M
    Polymers (Basel); 2021 Apr; 13(8):. PubMed ID: 33918625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].
    Li JL; Zheng CL; Liu JP; Zhu JB
    Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Self-Assembled Tumor-Penetrating Peptide-Modified Poly(l-γ-glutamylglutamine)-Paclitaxel Nanoparticles Based on Hydrophobic Interaction for the Treatment of Glioblastoma.
    Yu J; Sun L; Zhou J; Gao L; Nan L; Zhao S; Peng T; Han L; Wang J; Lu W; Zhang L; Wang Y; Yan Z; Yu L
    Bioconjug Chem; 2017 Nov; 28(11):2823-2831. PubMed ID: 28968068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy.
    Tahir N; Madni A; Correia A; Rehman M; Balasubramanian V; Khan MM; Santos HA
    Int J Nanomedicine; 2019; 14():4961-4974. PubMed ID: 31308666
    [No Abstract]   [Full Text] [Related]  

  • 32. Design and evaluation of a novel potential carrier for a hydrophilic antitumor drug: Auricularia auricular polysaccharide-chitosan nanoparticles as a delivery system for doxorubicin hydrochloride.
    Xiong W; Li L; Wang Y; Yu Y; Wang S; Gao Y; Liang Y; Zhang G; Pan W; Yang X
    Int J Pharm; 2016 Sep; 511(1):267-275. PubMed ID: 27424168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistically Enhanced Inhibitory Effects of Pullulan Nanoparticle-Mediated Co-Delivery of Lovastatin and Doxorubicin to Triple-Negative Breast Cancer Cells.
    Wu D; Chen Y; Wen S; Wen Y; Wang R; Zhang Q; Qin G; Yi H; Wu M; Lu L; Tao X; Deng X
    Nanoscale Res Lett; 2019 Sep; 14(1):314. PubMed ID: 31520223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel Delivery of Mitoxantrone with Hydrophobically Modified Pullulan Nanoparticles to Inhibit Bladder Cancer Cell and the Effect of Nano-drug Size on Inhibition Efficiency.
    Tao X; Tao T; Wen Y; Yi J; He L; Huang Z; Nie Y; Yao X; Wang Y; He C; Yang X
    Nanoscale Res Lett; 2018 Oct; 13(1):345. PubMed ID: 30377872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Combinational Approach Towards Treatment of Breast Cancer: an Analysis of Noscapine-Loaded Polymeric Nanoparticles and Doxorubicin.
    Esnaashari SS; Muhammadnejad S; Amanpour S; Amani A
    AAPS PharmSciTech; 2020 Jun; 21(5):166. PubMed ID: 32504144
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    El-Ghareb WI; Swidan MM; Ibrahim IT; Abd El-Bary A; Tadros MI; Sakr TM
    Int J Pharm; 2020 Aug; 586():119514. PubMed ID: 32565281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Polyelectrolyte layer-by-layer assembled lipid nanoparticles for improving oral absorption of doxorubicin].
    Shen AJ; Xia DN; Gan Y; Li J
    Yao Xue Xue Bao; 2016 Jul; 51(7):1136-43. PubMed ID: 29897223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytotoxicity study of Piper nigrum seed mediated synthesized SnO
    Tammina SK; Mandal BK; Ranjan S; Dasgupta N
    J Photochem Photobiol B; 2017 Jan; 166():158-168. PubMed ID: 27915029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
    Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z
    Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nano-delivery vehicle based on chlorin E6, photodynamic therapy, doxorubicin chemotherapy provides targeted treatment of HER-2 negative, ανβ3-positive breast cancer.
    He Z; Jiang H; Zhang X; Zhang H; Cui Z; Sun L; Li H; Qian J; Ma J; Huang J
    Pharmacol Res; 2020 Oct; 160():105184. PubMed ID: 32946931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.